GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BCWorldPharm Co 200780.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

2,845

+3.08%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩75.80bn

FY2016FY2025

Net income

−₩4.90bn

FY2016FY2025

Free cash flow

₩1.57bn

FY2016FY2025

Shareholders' equity

₩71.28bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩75.80bn₩74.81bn₩75.11bn₩72.70bn₩62.08bn₩56.93bn₩51.73bn₩55.11bn₩50.21bn₩45.66bn
Gross profit₩30.59bn₩35.74bn₩39.43bn₩34.61bn₩25.69bn₩28.33bn₩24.07bn₩25.51bn₩24.24bn₩22.86bn
Research and development₩8.99bn₩7.78bn₩6.14bn₩8.37bn₩9.17bn₩9.31bn₩7.26bn₩7.24bn₩6.65bn₩6.56bn
Operating income₩2.00bn₩1.50bn₩6.37bn₩1.80bn−₩1.53bn₩3.28bn₩6.57bn₩9.28bn₩8.87bn₩6.91bn
Net income−₩4.90bn−₩4.43bn₩2.63bn₩281.3m−₩1.84bn₩4.66bn₩6.06bn₩8.68bn₩8.08bn₩6.47bn
Diluted earnings per share-416.19-376.74223.8623.91-156.65396.21514.761,023.59686.99550.33

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩176.80bn₩176.31bn₩184.11bn₩183.05bn₩179.36bn₩192.96bn₩172.78bn₩161.74bn₩118.34bn₩96.42bn
Cash and short-term investments—₩7.91bn₩11.17bn₩8.06bn₩4.50bn₩12.56bn₩3.46bn₩4.77bn₩5.22bn₩2.62bn
Total liabilities₩104.30bn₩99.65bn₩102.47bn₩103.50bn₩97.90bn₩91.27bn₩75.53bn₩71.65bn₩37.11bn₩22.54bn
Debt₩14.00bn₩71.12bn₩58.97bn₩56.87bn₩73.92bn₩59.25bn₩47.99bn₩45.78bn₩24.01bn₩11.76bn
Shareholders' equity₩71.28bn₩76.67bn₩81.64bn₩79.55bn₩81.46bn₩101.69bn₩97.24bn₩90.09bn₩81.23bn₩73.88bn
Shares outstanding12m12m12m12m12m12m12m8m12m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩5.58bn₩4.04bn₩10.94bn₩6.88bn−₩619.8m−₩5.50bn₩12.11bn₩5.34bn₩7.90bn₩243.7m
Capital spending−₩4.01bn−₩2.41bn−₩2.71bn−₩6.22bn−₩17.44bn−₩7.79bn−₩21.32bn−₩29.92bn−₩16.58bn−₩12.56bn
Free cash flow₩1.57bn₩1.63bn₩8.23bn₩666.2m−₩18.06bn−₩13.29bn−₩9.21bn−₩24.58bn−₩8.68bn−₩12.32bn
Dividends paid−₩542.7m−₩542.7m−₩542.7m−₩853.9m−₩853.9m−₩771.8m−₩775.3m−₩705.2m−₩641.7m−₩641.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩20.96bn₩19.83bn₩20.28bn₩19.25bn₩20.44bn₩15.82bn₩21.53bn₩17.52bn
Gross profit₩7.34bn₩8.00bn₩8.06bn₩7.12bn₩8.74bn₩8.62bn₩8.71bn₩8.31bn
Operating income₩147.3m₩1.92bn₩719.1m₩147.5m₩1.10bn−₩694.9m—₩333.3m
Net income−₩1.13bn₩332.9m−₩983.6m−₩1.11bn−₩746.2m−₩2.05bn₩148.5m−₩1.09bn
Diluted earnings per share-96.3928.30-83.60-94.57-63.42-174.6012.62-92.72
Cash from operations₩3.73bn−₩1.55bn₩1.13bn₩1.43bn₩1.16bn₩1.85bn₩4.04bn₩4.37bn
Capital spending−₩1.31bn−₩1.53bn−₩867.0m−₩1.63bn−₩1.22bn−₩283.0m−₩2.41bn−₩2.04bn
Free cash flow₩2.42bn−₩3.08bn₩263.0m−₩200.0m−₩62.0m₩1.57bn₩1.64bn₩2.33bn
Total assets₩173.61bn₩173.26bn₩176.80bn₩173.79bn₩174.78bn₩173.73bn₩176.31bn₩171.18bn
Cash and short-term investments—————₩7.14bn₩7.91bn₩7.01bn
Debt—₩15.33bn₩14.00bn₩14.13bn₩9.50bn₩63.05bn₩71.12bn₩68.90bn
Shareholders' equity₩69.54bn₩70.68bn₩71.28bn₩72.26bn₩73.38bn₩74.07bn₩76.67bn₩76.52bn

Financial ratios

Data as of 15 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin40.4%47.8%52.5%47.6%41.4%49.8%——
Operating margin2.6%2.0%8.5%2.5%-2.5%5.8%——
Net margin-6.5%-5.9%3.5%0.4%-3.0%8.2%——
Return on equity-6.9%-5.8%3.2%0.4%-2.3%4.6%——
Return on assets-2.8%-2.5%1.4%0.2%-1.0%2.4%——
Free cash flow yield——————93.3%136.6%
Revenue growth1.3%-0.4%3.3%17.1%9.0%10.1%——
Earnings growth10.5%-268.3%836.3%-115.3%-139.5%-23.0%——
Current ratio0.55x0.52x0.52x0.52x0.67x0.77x——
Debt to equity0.20x0.92x0.72x0.71x0.91x0.58x——
Equity ratio40.3%43.5%44.3%43.5%45.4%52.7%——
Interest coverage0.47x0.32x1.22x0.47x-0.74x1.36x——
R&D as a share of sales11.9%10.4%8.2%11.5%14.8%16.4%——
Buybacks as a share of market value——————-38.8%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.4%5.9%6.2%
Operating income3.6%-9.4%-11.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin44.0%47.0%46.6%47.2%
Operating margin2.3%3.9%3.2%7.8%
Net margin-6.2%-2.1%-0.9%4.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-13.2-11.323.9292.8-83.649.223.216.424.531.7
Price to sales0.90.70.81.12.54.02.72.63.94.5

Dividends and splits

Per share, in the currency the company pays

Paid for 10 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2019FY2017FY2016
Paid in the year100.00173.55482.64582.64582.645150.26375.13162.092
  • 11-for-10 split · 29 Dec 2025
  • 11-for-10 split · 27 Dec 2024
  • 11-for-10 split · 27 Dec 2019
  • 11-for-10 split · 27 Dec 2017
  • 11-for-10 split · 28 Dec 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.